The spinout’s semiconductor chips are purpose-built to work in the brain, enabling implants and other innovative devices that promise better management of conditions such as stroke, epilepsy and depression.
MintNeuro, an Imperial spinout developing specialised chips that enable devices to connect with the brain and nervous system, has raised $5 million from European and US investors. The money will be used to accelerate product launches, build new partnerships and support international expansion.